<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2020.00377</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Duck TRIM32 Functions in IFN-&#x003B2; Signaling Against the Infection of H5N6 Highly Pathogenic Avian Influenza Virus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Siyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Junsheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xue</surname> <given-names>Qian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Bingzhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname> <given-names>Zhuoliang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Jianni</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zu</surname> <given-names>Shaopo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Zuxian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Bingbing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Liao</surname> <given-names>Ming</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/194672/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jiao</surname> <given-names>Peirong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/182576/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>College of Veterinary Medicine, South China Agricultural University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Guangdong Laboratory for Lingnan Modern Agriculture</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Fabrizio Ceciliani, University of Milan, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Zhixun Xie, Guangxi Veterinary Research Institute, China; Jianhe Sun, Shanghai Jiao Tong University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Ming Liao <email>mliao&#x00040;scau.edu.cn</email></corresp>
<corresp id="c002">Peirong Jiao <email>prjiao&#x00040;scau.edu.cn</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Comparative Immunology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>377</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>12</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>02</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 Wu, Zhang, Xue, Liu, Huang, He, Huang, Zu, Chen, Zhao, Liao and Jiao.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Wu, Zhang, Xue, Liu, Huang, He, Huang, Zu, Chen, Zhao, Liao and Jiao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>In mammals, tripartite motif 32 (TRIM32) is essential for regulating host innate immune responses to viral infections. However, the antiviral effect of TRIM32 in birds has not been reported. Here, we cloned the full-length duck TRIM32 (duTRIM32) cDNA from total spleen RNA of Peking duck. DuTRIM32 consists of 682 amino acids and has 95.5% similarity in amino acid sequences with chicken TRIM32 and 84.9% similarity with human TRIM32, respectively. DuTRIM32 mRNA was found to be ubiquitously expressed in all tested tissues from healthy ducks. Overexpression of duTRIM32 significantly activated the IFN-&#x003B2; promoter and upregulated the mRNA levels of IFN-&#x003B2;, IRF7, and Mx, which indicates that duTRIM32 is involved in the type I IFN pathway. Furthermore, duTRIM32 was found to directly interact with duck STING (duSTING) and to contribute to the expression of IFN-&#x003B2; mediated by duSTING. The mRNA level of duTRIM32 was significantly upregulated in the lungs and spleens of H5N6 highly pathogenic avian influenza virus (HPAIV) infected ducks 3 days post-infection (DPI). Furthermore, overexpression of duTRIM32 could inhibit the replication of H5N6 HPAIV in duck embryo fibroblasts (DEFs). Therefore, these results indicate that duTRIM32 is involved in the type I IFN pathway and exhibit an antiviral effect against H5N6 HPAIV infection.</p></abstract>
<kwd-group>
<kwd>duck</kwd>
<kwd>TRIM32</kwd>
<kwd>STING</kwd>
<kwd>IFN-&#x003B2;</kwd>
<kwd>avian influenza virus</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="36"/>
<page-count count="10"/>
<word-count count="5609"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>After viral infection, the host innate immune system recognizes the conserved viral components named pathogen-associated molecular patterns (PAMPs) by host pattern recognition receptors (PRRs) (<xref ref-type="bibr" rid="B1">1</xref>). The recognition of PAMPs by PRRs activates the innate immune signaling pathway that induces the expression of type I interferons (IFNs) and pro-inflammatory cytokines to control viral infection (<xref ref-type="bibr" rid="B2">2</xref>). Various post-translational modifications such as phosphorylation, ubiquitination, methylation, and acetylation have emerged as critical regulators of immunity by influencing the PRR-dependent pathway (<xref ref-type="bibr" rid="B3">3</xref>). Protein ubiquitination is one of the major conventional post-translational modifications that regulate the innate immune signaling pathway by targeting PRRs or downstream adaptor molecules (<xref ref-type="bibr" rid="B4">4</xref>)<sub>.</sub> The ubiquitination process is a unique enzymatic cascade reaction. First, ubiquitin-activating enzymes (E1) activates ubiquitin in an ATP-dependent manner and then the activated ubiquitin is transferred to E2 ubiquitin-conjugating enzymes. Finally, E3 ubiquitin-ligating enzymes facilitate ubiquitination of the substrate. E3 ubiquitin-ligating enzymes are the center of this process that determines the specificity of the substrate (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>TRIM proteins are a family of E3 ubiquitin-ligating enzymes that contain a conserved N-terminal RBCC domain (RING finger/B-box/coiled coil) (<xref ref-type="bibr" rid="B6">6</xref>). Mammalian TRIM proteins could modulate the innate immune response by ubiquitinating the key molecules of the signaling pathway. For example, TRIM56 could catalyze STING for K63-linked ubiquitination to induce STING dimerization, thereby enhancing the innate immune response (<xref ref-type="bibr" rid="B7">7</xref>). TRIM31 could also interact with mitochondrial antiviral-signaling protein (MAVS) and target it to K63-linked polyubiquitination to promote the RIG-I-MAVS-mediated signaling pathways (<xref ref-type="bibr" rid="B8">8</xref>). In addition, some of the TRIM proteins have been demonstrated to inhibit viral replication by directly targeting viral proteins. For example, both TRIM14 and TRIM22 have been reported to inhibit the replication of HCV by targeting NS5A protein for degradation (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Recently, mammalian TRIM32 has attracted much attention for its critical roles in enhancing viral-triggered innate immune responses (<xref ref-type="bibr" rid="B11">11</xref>). TRIM32 could directly interact with PB1 to inhibit the replication of the influenza A virus (<xref ref-type="bibr" rid="B12">12</xref>). However, the role of TRIM32 in the bird innate immune signaling pathway has not been reported.</p>
<p>In mammals, the cyclic GMP-AMP synthase (cGAS) may sense and react to DNA viral infections via the cGAS-STING pathway (<xref ref-type="bibr" rid="B13">13</xref>). RIG-I like receptors could sense RNA virus infection to trigger an innate immune response through the RIG-I-MAVS pathway (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). STING is reported to participate in the RIG-I-MAVS pathways and is crucial for anti-RNA viral infection (<xref ref-type="bibr" rid="B16">16</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>). Several TRIM proteins, including TRIM29, TRIM30&#x003B1;, TRIM32, and TRIM56 have been reported to regulate the mammalian STING-mediated pathways (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). DuSTING was reported to activate the type I IFN pathway and exhibited antiviral effects against both DNA and RNA viruses (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). However, whether duTRIM32 regulates the duSTING-mediated pathway remains unknown.</p>
<p>In this study, we cloned the TRIM32 coding sequence from Peking duck and investigated the role of duTRIM32 in the type I IFN pathway and its antiviral effect on H5N6 HPAIV infection.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Viruses, Cells, and Animals</title>
<p>The H5N6 virus A/duck/Guangdong/16873/2016 (DK16873) used in this study was isolated from swabs of ducks at a live bird market in Guangdong, China in 2016. The H5N6 virus was isolated in 9-day-old specific-pathogen-free (SPF) embryonated hen eggs, using methods described in the literature (<xref ref-type="bibr" rid="B23">23</xref>). The 50% tissue culture infective dose (TCID<sub>50</sub>) of the H5N6 virus was determined by infection of DEFs; 50% egg infective doses (EID<sub>50</sub>) was determined by infection of embryonated hen eggs, and values were calculated using the Reed-Muench method (<xref ref-type="bibr" rid="B24">24</xref>). DEFs were derived from 9-day-old duck embryos and cultured in Dulbecco&#x00027;s modified Eagle medium (GIBCO, USA) complemented with 10% fetal bovine serum (GIBCO, USA). Four-week-old healthy Peking ducks were purchased from farms in Guangdong and housed in the isolators of the ABSL-3 facilities. The Peking ducks were confirmed to be serologically negative for avian influenza with a hemagglutination inhibition (HI) test.</p>
</sec>
<sec>
<title>Cloning and Sequence Analysis of the duTRIM32</title>
<p>According to the predicted sequence of duck-TRIM32 (duTRIM32) from the National Center for Biotechnology Information (Accession number: XP_005029948.1), primers were designed and used to amplify full-length coding sequence (CDS) of duTRIM32 cDNA from total spleen RNA of Peking ducks (<xref ref-type="table" rid="T1">Table 1</xref>). Amino acid sequences of different species TRIM32 were aligned using Clustal X2.1 software and edited with BOXSHADE (<ext-link ext-link-type="uri" xlink:href="https://embnet.vital-it.ch/software/BOX_form.html">https://embnet.vital-it.ch/software/BOX_form.html</ext-link>). The functional domains of duTRIM32 were predicted using the SMART program. MEGA software (vesion 4.0) was also used to conduct phylogenetic analysis of TRIM32 amino acid sequences of 10 species.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Primer sequences used in this study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="left"><bold>Primer sequences (5<sup>&#x02032;</sup> to 3<sup>&#x02032;</sup>)</bold></th>
<th valign="top" align="left"><bold>Purpose for</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">duTRIM32-F</td>
<td valign="top" align="left">ATGGCAACCACGGCACTGAA</td>
<td valign="top" align="left">To obtain sequence</td>
</tr>
<tr>
<td valign="top" align="left">duTRIM32-R</td>
<td valign="top" align="left">TTAAGGGGTGGAATATCT</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">duTRIM32-V5-F</td>
<td valign="top" align="left">TATGAATTCATGGCAACCACGGCACTGAA</td>
<td valign="top" align="left">Gene cloning</td>
</tr>
<tr>
<td valign="top" align="left">duTRIM32-V5-R</td>
<td valign="top" align="left">TCGCTCGAGTTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCTTACCAGGGGTGGAATATCT</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">duTRIM32-q-F</td>
<td valign="top" align="left">TCGCTGTGATTATTTCCTCG</td>
<td valign="top" align="left">qRT-PCR</td>
</tr>
<tr>
<td valign="top" align="left">duTRIM32-q-R</td>
<td valign="top" align="left">TCACCACCTGCCCGATCTGC</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">duIFN-&#x003B2;-q-F</td>
<td valign="top" align="left">CAGCATCAACAAGTACTTCA</td>
<td valign="top" align="left">qRT-PCR</td>
</tr>
<tr>
<td valign="top" align="left">duIFN-&#x003B2;-q-R</td>
<td valign="top" align="left">CTTCCGAAGTGGCTGGGAGA</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">duIRF7-q-F</td>
<td valign="top" align="left">CCACACCTGGATGTCACCAT</td>
<td valign="top" align="left">qRT-PCR</td>
</tr>
<tr>
<td valign="top" align="left">duIRF7-q-R</td>
<td valign="top" align="left">AGACGTGCTGCCCCGGCTGC</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">duMx-q-F</td>
<td valign="top" align="left">CCAGACCTGACACTAATTGAT</td>
<td valign="top" align="left">qRT-PCR</td>
</tr>
<tr>
<td valign="top" align="left">duMx-q-R</td>
<td valign="top" align="left">CACATTACATGGCACCACTAC</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">GAPDH-q-F</td>
<td valign="top" align="left">ATGTTCGTGATGGGTGTGAA</td>
<td valign="top" align="left">qRT-PCR</td>
</tr>
<tr>
<td valign="top" align="left">GAPDH-q-R</td>
<td valign="top" align="left">CTGTCTTCGTGTGTGGCTGT</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Expression Profiles of duTRIM32 in Healthy Ducks and H5N6 HPAIV Infected Ducks</title>
<p>To analyze the distribution of duTRIM32 in healthy ducks, three 4-week-old healthy ducks were euthanized humanely to collect tissues that included livers, pancreases, hearts, brains, kidneys, lungs, spleens, intestines, thymuses, bursa of Fabricius, and stomachs. The lung, spleen and brains are the major target tissues for H5 subtype AIVs infection, and our previous study have demonstrated that the host immune responses in these organs may influence the outcome of the infection (<xref ref-type="bibr" rid="B25">25</xref>). Therefore, we have quantified the expression of duTRIM32 in the lungs, spleens, and brains of the infected ducks to evaluate if duTRIM32 involved in the host immune response to H5N6 infection. To investigate the expression of duTRIM32 in H5N6 infected ducks, six 4-week-old ducks were inoculated intranasally with 10<sup>6</sup> EID<sub>50</sub> of DK16873 H5N6 HPAIV in a volume of 200 uL. At 12 h and 3 days post-inoculation, each of the three inoculated birds were euthanized humanely to collect lungs, brains and spleens. Three control ducks were treated with PBS in the same way and were also euthanized humanely to collect lungs, brains and spleens. Total RNA of the collected tissues were extracted using an Eastep&#x000AE;Super Total RNA Extraction Kit (Promega, USA) according to the manufacturer&#x00027;s instructions. Total RNA (1 &#x003BC;g) was reverse-transcribed into cDNA using M-MLV Reverse Transcriptase (Promega, USA) according to the manufacturer&#x00027;s protocol. Quantitative real-time PCR (qRT-PCR) was conducted using a GoTaq&#x000AE; qPCR Master Mix (Promega, USA) and was run on a Bio-Rad CFX96 Touch&#x02122; Real-Time PCR Detection System (Bio-Rad, USA) with the following settings: 5 min at 95&#x000B0;C, then 15 s at 95&#x000B0;C and 34 s at 62&#x000B0;C for 40 cycles.</p>
</sec>
<sec>
<title>Luciferase Reporter Assay</title>
<p>The obtained sequence of full length duTRIM32 was subcloned into the pCAGGS plasmid with specific primers (<xref ref-type="table" rid="T1">Table 1</xref>). Other plasmids and luciferase reporter plasmids used in this study (duSTING-HA, pGL3-IFN-&#x003B2;- Luc, pRL-TK, and pCAGGS-vector) were kept in our labatory and were constructed using previously described methods (<xref ref-type="bibr" rid="B26">26</xref>). For the luciferase reporter assay, expression plasimids (duTRIM32-V5 and duSTING-HA), reporter plasmids, pCAGGS-vector and pRL-TK were transfected into DEFs using the FuGENE HD transfection reagent (Promega, USA). The pRL-TK plasmid (Promega, Madison, WI, USA), encoding the Renilla luciferase protein, was used as an internal control plasmid to normalize transfection efficiency. In addition, we also used pAc-GFP to observe the transfection efficiency. After 24 h, DEFs were collected and tested for luciferase activities using the dual-luciferase Assay System (Promega, USA) according to the manufacturer&#x00027;s instructions.</p>
</sec>
<sec>
<title>Overexpression of duTRIM32 and qRT-PCR Analysis</title>
<p>DEFs were seeded on 6-well plates and cultured until the cells were 70% confluent. DuTRIM32-V5 or pCAGGS-vector was then transfected into the corresponding well (<italic>n</italic> = 3) using the FuGENE HD transfection reagent (Promega, USA) and cultured at 37&#x000B0;C with 5% CO<sub>2</sub>. After 24 h, DEFs were collected and the mRNA of IFN-&#x003B2;, IRF7, and Mx were tested using qRT-PCR described above.</p>
</sec>
<sec>
<title>Coimmunoprecipitation Analysis</title>
<p>Coimmunoprecipitation (Co-IP) assays were conducted to analyze the interaction between duTRIM32 and duSTING. For Co-IP experiments, 293T cells were seeded on 100 mm dishes (10<sup>7</sup> cells/dish) overnight. Expression plasmids or empty plasmids were used to transfect 293T cells. After 24 h, cells were lysed using cell lysis buffer (P0013, Beyotime, China) containing 1 mM PMSF. Lysates were centrifuged at 12,000 g, for 15 min at 4&#x000B0;C and precipitated with anti-HA mAb, in conjunction with protein G Agarose beads (ThermoFisher Scientific, USA) for at least 4 h at 4&#x000B0;C. The beads were washed with cold PBS 5 times (10 min/wash), and subsequently eluted with SDS loading buffer by boiling for 10 min. Proteins isolated from the beads and the cell lysates were separated by SDS-PAGE. In addition, the separated proteins were electroblotted onto polyvinylidene fluoride (PVDF) membranes (Millipore, Bedford, MA, USA). The membranes was blocked with 5% BSA in phosphate buffer solution and was then incubated for 1 h with mouse anti-HA and anti-V5 antibodies (Sigma, German) at a dilution of 1:2,000 and 1:3,000, respectively. The goat anti-mouse-IRDye 800 (LI-COR Biosciences, Lincoln, NE USA) was used as the secondary antibody at a 1:10,000. dilution. To determine whether ubiquitination of duSTING can be detected after the interaction, the 293T cells were co-transfected with duSTING-Myc, Ub-HA, and duTRIM32-V5. The duSTING-myc and Ub-HA transfected group was used as a control group. Cell lysates were immunoprecipitated with anti-Myc mAb, in conjunction with protein G Agarose beads (ThermoFisher Scientific, USA) and the immunoprecipitates were analyzed by Western blot with mouse anti-HA antibodies (Sigma, German) at a dilution of 1:2,000. The secondary antibody was indicated before.</p>
</sec>
<sec>
<title>Antiviral Effect of duTRIM32 on H5N6 HPAIV</title>
<p>Antiviral experiments were conducted using previously described methods (<xref ref-type="bibr" rid="B26">26</xref>). DEFs were seeded on 12-well plates and cultured until cells were 70% confluent. Expression plasmids (duTRIM32-V5) or empty vectors was transfected into DEFs using FuGENE HD transfection reagent. After 24 h, DEFs were infected with DK16873 H5N6 virus at a dose of 5 TCID<sub>50</sub>. Cell supernatants were collected at 12, 24, 36, and 48 HPI. DEFs were used to determine TCID<sub>50</sub> titers.</p>
</sec>
<sec>
<title>Ethics Statement</title>
<p>All experiments with H5N6 HPAIV were conducted in Animal Biosafety Level 3 (ABSL-3) and Biosafety Level 3 (BSL-3) facilities. The protocol (SCAUABSL2017-011) was approved by the Experimental Animal Administration and Ethics Committee of the South China Agricultural University.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>GraphPad Prism 7.0 software (GraphPad Software Inc, USA) was used to perform statistical analysis. The Student&#x00027;s <italic>t</italic>-test was used to analyze the statistical significance of the differences. A <italic>p</italic>-value &#x0003C; 0.05 was considered to be statistically significant (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05; <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Cloning and Sequence Analysis of the duTRIM32</title>
<p>Based on the predicted sequence of duTRIM32 on the National Center for Biotechnology Information (NCBI), primers were designed and used to amplify full-length duTRIM32 cDNA from total duck spleen RNA. The full-length duTRIM32 contains 2,049 bp, encoding 682 amino acids (<xref ref-type="fig" rid="F1">Figure 1</xref>). Sequence alignment results revealed that duTRIM32 shares 98.3% similarity in amino acid sequences with goose TRIM32, 95.5% with chicken TRIM32, 84.9% with human TRIM32, 84.3 % with mouse TRIM32 and 61.5% with fish TRIM32, respectively. Phylogenetic analysis revealed that duTRIM32 is clustered into the bird clade (<xref ref-type="fig" rid="F2">Figure 2</xref>). The SMART program and the well-understood structure of human TRIM32 were used to predict the functional domains of duTRIM32. Results indicate that duTRIM32 contains a conserved RING-finger domain, a BBOX domain and a coiled-coil domain, which are similar to those of mammalian TRIM32 (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Alignment of Peking duck TRIM32 amino acid sequence with goose, chicken, human, and mouse TRIM32. The sequences of TRIM32 are derived from GenBank. The accession numbers are goose (XP_013038246.1), chicken (XP_015135179.2), human (NP_036342.2), and mouse (NP_444314.2). The predicted motifs of duck TRIM32 (RING, a B box/coiled-coil domain and a NHL domain) were indicated on the sequences.</p></caption>
<graphic xlink:href="fimmu-11-00377-g0001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>A phylogenetic tree of duck TRIM32 and other animal TRIM32 were generated by MEGA 4.0 with the neighbor-joining method. The sequences are derived from GenBank. The accession numbers are goose (XP_013038246.1), chicken (XP_015135179.2), human (NP_036342.2), mouse (NP_444314.2), cattle (NP_001069292.1), dog (XP_005627017.1), pig (XP_005660438.1), zebrafish (NP_001107066.1), and grouper (AQD20583.1).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0002.tif"/>
</fig>
</sec>
<sec>
<title>Expression Profiles of duTRIM32 in Healthy Ducks</title>
<p>To analyze the expression profiles of duTRIM32 in healthy ducks, we performed qRT-PCR to determine the expression of duTRIM32 in different tissues. qRT-PCR assays were conducted as described in the Materials and Methods. Results indicate the highest expression of duTRIM32 is in the liver, followed by the pancreas, heart, brain, kidney, lung, spleen, intestine, thymus, bursa of Fabricius, and stomach (<xref ref-type="fig" rid="F3">Figure 3</xref>). Therefore, our results indicated that duTRIM32 is ubiquitously expressed in all the tested tissues of healthy ducks.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Relative expression levels of duTRIM32 in healthy ducks. The real-time RT-PCR was conducted to detect the transcription levels of duTRIM32 in ducks&#x00027; tissues. GAPDH was chosen as the control gene. Data were normalized to the stomach and error bars indicated the SD.</p></caption>
<graphic xlink:href="fimmu-11-00377-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Expression of duTRIM32 in Ducks Infected With H5N6 HPAIV</title>
<p>To investigate if duTRIM32 is involved in the host immune response to viral infection, we quantified the mRNA levels of duTRIM32 in the lungs, spleens, and brains of H5N6 HPAIV infected ducks using techniques described in the Materials and Methods. Results from these studies indicated that the mRNA of duTRIM32 is slightly changed at 12 HPI in the lungs, spleens and brains. Notably, duTRIM32 was found to be upregulated in these tissues of the H5N6 HPAIV infected ducks at 3 days post-infection (DPI), especially in the lungs and spleens, with a fold increases of 7.23 (<italic>P</italic> &#x0003C; 0.05) and 5.29 (<italic>P</italic> &#x0003C; 0.05), respectively (<xref ref-type="fig" rid="F4">Figure 4</xref>). Therefore, our results suggest that duTRIM32 might be involved in the host innate immune response to H5N6 HPAIV infection.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Relative expression levels of duTRIM32 in the lungs, spleens and brains of DK16873 H5N6 HPAIV infected ducks were quantified by real-time RT-PCR. The experimental ducks were inoculated with 10<sup>6</sup> EID<sub>50</sub> of DK16873 H5N6 HPAIVs. Control ducks were treated with PBS in the same way. Each bar shows the mRNA level of the target gene relative to those in the control group. All data were expressed as means &#x000B1; SD, the Student&#x00027;s <italic>t</italic>-test was used to analyze the differences. (&#x0002A;<italic>p</italic> &#x0003C; 0.05; &#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0004.tif"/>
</fig>
</sec>
<sec>
<title>Overexpression of duTRIM32 Activates the Type I IFN Pathway</title>
<p>To determine whether duTRIM32 functions in the type I IFN pathway, we performed a luciferase reporter assay to test the ability of duTRIM32 to activate the IFN-&#x003B2; promoter. The luciferase reporter assay was completed as described in the Materials and Methods. The pCAGGS is an empty plasmid and used as a negative control in this study. The results show that transfection of pCAGGS could not activate the IFN-&#x003B2; promoter (<xref ref-type="fig" rid="F5">Figure 5</xref>). These results indicate that overexpression of duTRIM32 can significantly activate the IFN-&#x003B2; promoter (4.34-fold, <italic>P</italic> &#x0003C; 0.05) (<xref ref-type="fig" rid="F5">Figure 5</xref>). In addition, we also quantified the mRNA of IFN-&#x003B2;, IRF7 and Mx in the duTRIM32-transfected DEFs. Results from these studies indicate that duTRIM32 significantly upregulates the expression of IFN-&#x003B2; (4.58-fold, <italic>P</italic> &#x0003C; 0.05), IRF7 (3.67-fold, <italic>P</italic> &#x0003C; 0.05) and Mx (5.26-fold, <italic>P</italic> &#x0003C; 0.05) (<xref ref-type="fig" rid="F6">Figure 6</xref>). Therefore, these results reveal that duTRIM32 can activate the type I IFN pathway and upregulates the expression of the related antiviral genes.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Overexpression of duTRIM32 activates the IFN-&#x003B2; promoter. The DEFs (24 wells) were co-transfected with pGL3-IFN-&#x003B2;-Luc (0.1 &#x003BC;g/well), PRL-TK plasmids (0.01 &#x003BC;g/well), pCAGGS-duSTING-HA (0.3 &#x003BC;g/well), or empty vector (0.3 &#x003BC;g/well). All data were expressed as means &#x000B1; SD, the Student&#x00027;s <italic>t</italic>-test was used to analyze the differences. (&#x0002A;<italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0005.tif"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>The DEFs respond to overexpression of the duTRIM32. The DEFs (6 wells) were transfected with pCAGGS-duTRIM32-V5 (2 &#x003BC;g/well) or empty vector (2 &#x003BC;g/well). The relative expression of IFN&#x003B2;, IRF7, and Mx genes were detected by real-time RT-PCR. All data were expressed as means &#x000B1; SD, the Student&#x00027;s <italic>t</italic>-test was used to analyze the differences. (&#x0002A;<italic>p</italic> &#x0003C; 0.05; &#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0006.tif"/>
</fig>
</sec>
<sec>
<title>duTRIM32 Interacts With duSTING and Contributes to the Expression of IFN-&#x003B2; Mediated by duSTING</title>
<p>Mammalian TRIM32 was found to interact with STING and to contribute to the expression of IFN-&#x003B2; mediated by duSTING, thereby positively regulating the type I IFN pathway (<xref ref-type="bibr" rid="B11">11</xref>). We performed a dual luciferase reporter assay to determine whether duTRIM32 contributes to duSTING-mediated expression of IFN-&#x003B2;. Results from these studies showed that both duTRIM32 and duSTING can activate the IFN-&#x003B2; promoter, with fold increases of 4.34 (<italic>P</italic> &#x0003C; 0.05) and 28.63 (<italic>P</italic> &#x0003C; 0.05), respectively. Co-transfection of duTRIM32 and duSTING exhibited stronger activation of the IFN-&#x003B2; promoter than the transfection of duSTING, with a fold increase of 43.03 (<italic>P</italic> &#x0003C; 0.05). But the increased level between duTRIM32 and duSTING co-transfection group and duSTING transfection group is &#x0003C;2-folds (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>DuTRIM32 contributes to duSTING-mediated expression of IFN-&#x003B2;. The DEFs (24 wells) were co-transfected with pGL3-IFN-&#x003B2;-Luc (0.1 &#x003BC;g/well), PRL-TK plasmids (0.01 &#x003BC;g/well), pCAGGS-duTRIM32-V5 (0.3 &#x003BC;g/well), and/or pCAGGS-duSTING-HA (0.3 &#x003BC;g/well). After 24 h, DEFs were collected and tested for luciferase activities using the dual-luciferase Assay System. All data were expressed as means &#x000B1; SD, the Student&#x00027;s <italic>t</italic>-test was used to analyze the differences. (&#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.01).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0007.tif"/>
</fig>
<p>In addition, we co-transfected duTRIM32 and duSTING expression plasmids into 293T cells and the interaction between duTRIM32 and duSTING was analyzed by Co-IP assays. Results showed that duTRIM32 directly interacted with duSTING. Both duTRIM32 and duSTING were correctly expressed in 293T cells, with a molecular weight of 76 kDa and 43 kDa, respectively (<xref ref-type="fig" rid="F8">Figure 8</xref>, <xref ref-type="supplementary-material" rid="SM1">Supplementary Material</xref>). These results confirmed that duTRIM32 can directly interact with duSTING. Furthermore, we found that duTRIM32 was demonstrated to ubiquitinate duSTING in 293T cells (<xref ref-type="fig" rid="F9">Figure 9</xref>).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>Identification of the interaction between duTRIM32 and duSTING by Co-IP assays. The 293T cells were transfected with the pCAGGS-duTRIM32-V5 and/or pCAGGS-duSTING-HA. After 24 h, the lysates were immunoprecipitated with anti-HA beads, followed by immunoblotting analysis with the indicated Abs.</p></caption>
<graphic xlink:href="fimmu-11-00377-g0008.tif"/>
</fig>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p>Ubiquitination of duSTING by duTRIM32. The 293T cells were co-transfected with duSTING-Myc, Ub-HA, and duTRIM32-V5. The duSTING-Myc and Ub-HA transfected group was used as a control group. Cell lysates were immunoprecipitated with anti-Myc mAb, in conjunction with protein G Agarose beads (ThermoFisher Scientific, USA) and the immunoprecipitates were analyzed by Western blot.</p></caption>
<graphic xlink:href="fimmu-11-00377-g0009.tif"/>
</fig>
<p>Therefore, our results revealed that duTRIM32 can interact with duSTING and contributes to duSTING-mediated expression of IFN-&#x003B2;.</p>
</sec>
<sec>
<title>Antiviral Effect of duTRIM32 on H5N6 HPAIV Infection</title>
<p>To investigate the antiviral effects of duTRIM32, we transfected duTRIM32 or an empty vector in DEFs. DEFs were then infected with DK16873 H5N6 HPAIV at 24 h post-transfection. Samples were collected at 12, 24, 36, and 48 h post-infection. The viral titers of the collected samples were measured by the TCID<sub>50</sub> method in DEFs. Results indicated that the viral titers of H5N6 HPAIV in the duTRIM32-transfected group were lower than that of the empty vector transfected group. Notably, overexpression of duTRIM32 could significantly inhibit the replication of H5N6 HPAIV at 24 HPI (<italic>P</italic> &#x0003C; 0.05) and 36 HPI (<italic>P</italic> &#x0003C; 0.05) (<xref ref-type="fig" rid="F10">Figure 10</xref>). Therefore, our results revealed that duTRIM32 can inhibit the H5N6 HPAIV infection.</p>
<fig id="F10" position="float">
<label>Figure 10</label>
<caption><p>DuTRIM32 inhibits the replication of H5N6 HPAIV in DEFs. The DEFs (12 wells) were transfected with either the pCAGGS-duTRIM32-V5 (1 &#x003BC;g/well) or the empty vector (1 &#x003BC;g/well). At 24 h post-transfection, the transfected cells were infected with DK16873 H5N6 HPAIVs (5 TCID<sub>50</sub>). Cell supernatants were collected at 12, 24, 36, and 48 h post-infection and analyzed for their TCID<sub>50</sub> titers in DEFs. Virus titers are expressed as means &#x000B1; standard deviation in log<sub>10</sub> TCID<sub>50</sub>/mL, and the Student&#x00027;s <italic>t</italic>-test was used to analyze the differences. (&#x0002A;<italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fimmu-11-00377-g0010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>TRIM proteins are involved in various cellar physiological processes, such as cell differentiation, apoptosis, tumorigenesis, and innate immunity (<xref ref-type="bibr" rid="B27">27</xref>). Over the last decade, more and more mammalian TRIM proteins were found to be important immunomodulatory effectors of the innate immunity against viral infections. For example, TRIM5, TRIM21, TRIM23, TRIM31, TRIM32, TRIM56, and TRIM65 are reported to positively regulate the type I IFN pathway (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B28">28</xref>&#x02013;<xref ref-type="bibr" rid="B31">31</xref>). Some TRIM proteins, like TRIM26 and TRIM40 are reported to act as negative regulators for innate immune responses (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Among them, mammalian TRIM32 have been well-elucidated for its critical roles in regulating antiviral innate immune responses (<xref ref-type="bibr" rid="B11">11</xref>). However, the antiviral effect of TRIM32 in birds has not been reported.</p>
<p>In our study, we cloned the full-length duTRIM32 cDNA from Peking duck. DuTRIM32 was ubiquitously expressed in all the tested tissues of healthy ducks, which suggests that duTRIM32 might be involved in various cellar processes. Phylogenetic analysis revealed that duTRIM32 is clustered into the bird clade and is most similar to goose TRIM32 (up to 98.3%), and shares 84.9% similarity with mammalian TRIM32. Similar to human TRIM32, duTRIM32 was also found to contain a conserved RING-finger domain, a BBOX domain and a coiled-coil domain, which suggested that duTRIM32 might possess the same functions of mammalian TRIM32.</p>
<p>Recent studies have demonstrated that mammalian TRIM32 is able to positively regulate the type I IFN pathway and cellular antiviral response. Overexpression of mammalian TRIM32 could activate the IFN-&#x003B2; promoter and upregulate the mRNA expression of virus-triggered IFN-&#x003B2;, so as to inhibit the replication of VSV in infected cells (<xref ref-type="bibr" rid="B11">11</xref>). In our study, we found that overexpression of duTRIM32 significantly activates the IFN-&#x003B2; promoter and upregulates the expression of related genes in the type I IFN pathway (e.g., IFN-&#x003B2;, IRF7, and Mx). Therefore, our results suggested that duTRIM32 was involved in the activation of the type I IFN pathway.</p>
<p>Reports indicate that the mammalian STING-mediated type I IFN pathway is regulated by several TRIM proteins. Mammalian TRIM32 could target STING for K63-linked ubiquitination and was found to contribute to STING mediated expression of IFN-&#x003B2; (<xref ref-type="bibr" rid="B11">11</xref>). However, TRIM29, and TRIM30a were reported to induce K48-linked ubiquitination of STING, thereby degrading STING and inhibiting the innate immune response (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). A recent study showed that duSTING is involved in the induction of IFN-&#x003B2; and inhibits the replication of the duck plague virus <italic>in vitro</italic> (<xref ref-type="bibr" rid="B21">21</xref>). In addition, overexpression of duSTING was also demonstrated to inhibit the replication of H9N2 AIV (<xref ref-type="bibr" rid="B22">22</xref>). In this study, we found that duTRIM32 directly interacts with duSTING and contributes to the production of IFN-&#x003B2; mediated by duSTING, though the increase level is &#x0003C;2-folds. Furthermore, our results showed that duTRIM32 was demonstrated to ubiquitinate duSTING in 293T cells. Our results suggest that duTRIM32 can positively regulate duSTING mediated by the type I IFN pathway by directly interacting with duSTING.</p>
<p>Several mammalian TRIM proteins are reported to be involved in host innate immune responses to influenza A virus infection. Overexpression of TRIM19 (PML) may inhibit the replication of the influenza virus (<xref ref-type="bibr" rid="B34">34</xref>). Both TRIM22 and TRIM41 have been found to inhibit the replication of influenza A virus by degrading NP proteins (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). TRIM32 was also reported as a restriction factor for influenza A viral infection (<xref ref-type="bibr" rid="B12">12</xref>). In this study, we found that the expression of duTRIM32 was significantly upregulated in the lungs and spleens of the H5N6 HPAIV infected ducks at 3 DPI, which suggests that duTRIM32 might be involved in the duck immune response to H5N6 HPAIV infection. Overexpression of duTRIM32 could inhibit the replication of H5N6 HPAIV in infected cells. However, the inhibitory effect of duTRIM32 on H5N6 HPAIV is moderate and not complete. These results reveal that duTRIM32 may also act as an antiviral factor to H5N6 HPAIV infection.</p>
<p>Taken together, we have found that duTRIM32 can positively regulate duSTING mediated type I IFN pathway by directly interacting with duSTING. DuTRIM32 was found to exhibit an antiviral effect against H5N6 HPAIV infection. This helps to delineate the function of duck TRIM proteins in regulating the type I IFN pathway and their antiviral effect on AIV.</p>
</sec>
<sec sec-type="data-availability-statement" id="s5">
<title>Data Availability Statement</title>
<p>The datasets generated for this study are available on request to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Experimental Animal Administration and Ethics Committee of the South China Agricultural University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>SW and PJ designed this study, performed the experiments, and drafted the manuscript. JZ, QX, JL, BH, ZH, JH, SZ, ZC, and BZ assisted with animal experiment. ML participated in writing the discussion. All authors have read and approved the final manuscript.</p>
<sec>
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>We thank the National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control; the Key Laboratory of Zoonosis, Ministry of Agriculture and Rural Affairs; the Key Laboratory of Animal Vaccine Development, Ministry of Agriculture and Rural Affairs; the Key Laboratory of Zoonoses Control and Prevention of Guangdong.</p></ack>
<sec sec-type="supplementary-material" id="s8">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2020.00377/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2020.00377/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname> <given-names>S</given-names></name> <name><surname>Uematsu</surname> <given-names>S</given-names></name> <name><surname>Takeuchi</surname> <given-names>O</given-names></name></person-group>. <article-title>Pathogen recognition and innate immunity</article-title>. <source>Cell.</source> (<year>2006</year>) <volume>124</volume>:<fpage>783</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.02.015</pub-id><pub-id pub-id-type="pmid">16497588</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname> <given-names>R</given-names></name></person-group>. <article-title>Recognition of microorganisms and activation of the immune response</article-title>. <source>Nature.</source> (<year>2007</year>) <volume>449</volume>:<fpage>819</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/nature06246</pub-id><pub-id pub-id-type="pmid">17943118</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Qian</surname> <given-names>C</given-names></name> <name><surname>Cao</surname> <given-names>X</given-names></name></person-group>. <article-title>Post-translational modification control of innate immunity</article-title>. <source>Immunity.</source> (<year>2016</year>) <volume>45</volume>:<fpage>15</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.020</pub-id><pub-id pub-id-type="pmid">27438764</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>The role of ubiquitylation in immune defence and pathogen evasion</article-title>. <source>Nat Rev Immunol.</source> (<year>2011</year>) <volume>12</volume>:<fpage>35</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/nri3111</pub-id><pub-id pub-id-type="pmid">22158412</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pickart</surname> <given-names>CM</given-names></name></person-group>. <article-title>Mechanisms underlying ubiquitination</article-title>. <source>Annu Rev Biochem.</source> (<year>2001</year>) <volume>70</volume>:<fpage>503</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.70.1.503</pub-id><pub-id pub-id-type="pmid">11395416</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nisole</surname> <given-names>S</given-names></name> <name><surname>Stoye</surname> <given-names>JP</given-names></name> <name><surname>Saib</surname> <given-names>A</given-names></name></person-group>. <article-title>TRIM family proteins: retroviral restriction and antiviral defence</article-title>. <source>Nat Rev Microbiol.</source> (<year>2005</year>) <volume>3</volume>:<fpage>799</fpage>&#x02013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1248</pub-id><pub-id pub-id-type="pmid">16175175</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuchida</surname> <given-names>T</given-names></name> <name><surname>Zou</surname> <given-names>J</given-names></name> <name><surname>Saitoh</surname> <given-names>T</given-names></name> <name><surname>Kumar</surname> <given-names>H</given-names></name> <name><surname>Abe</surname> <given-names>T</given-names></name> <name><surname>Matsuura</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA</article-title>. <source>Immunity.</source> (<year>2010</year>) <volume>33</volume>:<fpage>765</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.013</pub-id><pub-id pub-id-type="pmid">21074459</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Chu</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Wu</surname> <given-names>H</given-names></name> <name><surname>Song</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination</article-title>. <source>Nat Immunol.</source> (<year>2017</year>) <volume>18</volume>:<fpage>214</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3641</pub-id><pub-id pub-id-type="pmid">27992402</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name> <name><surname>Guo</surname> <given-names>L</given-names></name> <name><surname>Peng</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>32336</fpage>. <pub-id pub-id-type="doi">10.1038/srep32336</pub-id><pub-id pub-id-type="pmid">27578425</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>C</given-names></name> <name><surname>Zhao</surname> <given-names>X</given-names></name> <name><surname>Sun</surname> <given-names>D</given-names></name> <name><surname>Yang</surname> <given-names>L</given-names></name> <name><surname>Chong</surname> <given-names>C</given-names></name> <name><surname>Pan</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Interferon alpha (IFN&#x003B1;)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A</article-title>. <source>Cell Mol Immunol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>94</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2014.131</pub-id><pub-id pub-id-type="pmid">25683609</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Hu</surname> <given-names>MM</given-names></name> <name><surname>Wang</surname> <given-names>YY</given-names></name> <name><surname>Shu</surname> <given-names>HB</given-names></name></person-group>. <article-title>TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination</article-title>. <source>J Biol Chem.</source> (<year>2012</year>) <volume>287</volume>:<fpage>28646</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.362608</pub-id><pub-id pub-id-type="pmid">22745133</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>B</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Ding</surname> <given-names>H</given-names></name> <name><surname>Schwamborn</surname> <given-names>JC</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Dorf</surname> <given-names>ME</given-names></name></person-group>. <article-title>TRIM32 Senses and restricts influenza A virus by ubiquitination of PB1 polymerase</article-title>. <source>PLoS Pathog.</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004960</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004960</pub-id><pub-id pub-id-type="pmid">26057645</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L</given-names></name> <name><surname>Wu</surname> <given-names>J</given-names></name> <name><surname>Du</surname> <given-names>F</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway</article-title>. <source>Science.</source> (<year>2013</year>) <volume>339</volume>:<fpage>786</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1126/science.1232458</pub-id><pub-id pub-id-type="pmid">23258413</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoneyama</surname> <given-names>M</given-names></name> <name><surname>Kikuchi</surname> <given-names>M</given-names></name> <name><surname>Natsukawa</surname> <given-names>T</given-names></name> <name><surname>Shinobu</surname> <given-names>N</given-names></name> <name><surname>Imaizumi</surname> <given-names>T</given-names></name> <name><surname>Miyagishi</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses</article-title>. <source>Nat Immunol.</source> (<year>2004</year>) <volume>5</volume>:<fpage>730</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ni1087</pub-id><pub-id pub-id-type="pmid">15208624</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gack</surname> <given-names>MU</given-names></name></person-group>. <article-title>Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens</article-title>. <source>J Virol.</source> (<year>2014</year>) <volume>88</volume>:<fpage>5213</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.03370-13</pub-id><pub-id pub-id-type="pmid">24623415</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname> <given-names>H</given-names></name> <name><surname>Barber</surname> <given-names>GN</given-names></name></person-group>. <article-title>STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling</article-title>. <source>Nature.</source> (<year>2008</year>) <volume>455</volume>:<fpage>674</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature07317</pub-id><pub-id pub-id-type="pmid">18724357</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>B</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>YY</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Diao</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation</article-title>. <source>Immunity.</source> (<year>2008</year>) <volume>29</volume>:<fpage>538</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.09.003</pub-id><pub-id pub-id-type="pmid">18818105</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nitta</surname> <given-names>S</given-names></name> <name><surname>Sakamoto</surname> <given-names>N</given-names></name> <name><surname>Nakagawa</surname> <given-names>M</given-names></name> <name><surname>Kakinuma</surname> <given-names>S</given-names></name> <name><surname>Mishima</surname> <given-names>K</given-names></name> <name><surname>Kusano-Kitazume</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity</article-title>. <source>Hepatology.</source> (<year>2013</year>) <volume>57</volume>:<fpage>46</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/hep.26017</pub-id><pub-id pub-id-type="pmid">22911572</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Lian</surname> <given-names>Q</given-names></name> <name><surname>Yang</surname> <given-names>B</given-names></name> <name><surname>Yan</surname> <given-names>S</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>He</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>TRIM30&#x003B1; is a negative-feedback regulator of the intracellular DNA and DNA virus-triggered response by targeting STING</article-title>. <source>PLoS Pathog.</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1005012</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005012</pub-id><pub-id pub-id-type="pmid">26114947</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>A</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>XC</given-names></name> <name><surname>Zeng</surname> <given-names>MS</given-names></name> <etal/></person-group>. <article-title>TRIM29 promotes DNA virus infections by inhibiting innate immune response</article-title>. <source>Nat Commun.</source> (<year>2017</year>) <volume>8</volume>:<fpage>945</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00101-w</pub-id><pub-id pub-id-type="pmid">29038422</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S</given-names></name> <name><surname>Wu</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Jia</surname> <given-names>R</given-names></name> <name><surname>Zhu</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Duck stimulator of interferon genes plays an important role in host anti-duck plague virus infection through an IFN-dependent signalling pathway</article-title>. <source>Cytokine.</source> (<year>2018</year>) <volume>102</volume>:<fpage>191</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2017.09.008</pub-id><pub-id pub-id-type="pmid">28969942</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>S</given-names></name> <name><surname>Niu</surname> <given-names>Q</given-names></name> <name><surname>Zhu</surname> <given-names>W</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Functional characterization of duck STING in IFN-&#x003B2; induction and Anti-H9N2 avian influenza viruses infections</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>2224</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.02224</pub-id><pub-id pub-id-type="pmid">31620135</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname> <given-names>P</given-names></name> <name><surname>Song</surname> <given-names>Y</given-names></name> <name><surname>Huang</surname> <given-names>J</given-names></name> <name><surname>Xiang</surname> <given-names>C</given-names></name> <name><surname>Cui</surname> <given-names>J</given-names></name> <name><surname>Wu</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>H7N9 avian influenza virus is efficiently transmissible and induces an antibody response in chickens</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>789</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00789</pub-id><pub-id pub-id-type="pmid">29706970</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname> <given-names>AK</given-names></name> <name><surname>Fezio</surname> <given-names>WL</given-names></name></person-group>. <article-title>A computer program for estimating LD50 and its confidence limits using modified behrens-reed-muench cumulant method</article-title>. <source>Drug Chem Toxicol.</source> (<year>1981</year>) <volume>4</volume>:<fpage>297</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.3109/01480548109018136</pub-id><pub-id pub-id-type="pmid">7338208</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>L</given-names></name> <name><surname>Jiao</surname> <given-names>P</given-names></name> <name><surname>Song</surname> <given-names>Y</given-names></name> <name><surname>Cao</surname> <given-names>L</given-names></name> <name><surname>Yuan</surname> <given-names>R</given-names></name> <name><surname>Gong</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Host immune responses of ducks infected with H5N1 highly pathogenic avian influenza viruses of different pathogenicities</article-title>. <source>Vet Microbiol.</source> (<year>2013</year>) <volume>166</volume>:<fpage>386</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2013.06.019</pub-id><pub-id pub-id-type="pmid">23920409</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>L</given-names></name> <name><surname>Cui</surname> <given-names>J</given-names></name> <name><surname>Song</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>S</given-names></name> <name><surname>Han</surname> <given-names>F</given-names></name> <name><surname>Yuan</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Duck MDA5 functions in innate immunity against H5N1 highly pathogenic avian influenza virus infections</article-title>. <source>Vet Res.</source> (<year>2014</year>) <volume>45</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/1297-9716-45-66</pub-id><pub-id pub-id-type="pmid">24939427</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meroni</surname> <given-names>G</given-names></name> <name><surname>Diez-Roux</surname> <given-names>G</given-names></name></person-group>. <article-title>TRIM/RBCC, a novel class of &#x00027;single protein RING finger&#x00027; E3 ubiquitin ligases</article-title>. <source>Bioessays.</source> (<year>2005</year>) <volume>27</volume>:<fpage>1147</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1002/bies.20304</pub-id><pub-id pub-id-type="pmid">16237670</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>K</given-names></name> <name><surname>Shi</surname> <given-names>HX</given-names></name> <name><surname>Liu</surname> <given-names>XY</given-names></name> <name><surname>Shan</surname> <given-names>YF</given-names></name> <name><surname>Wei</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response</article-title>. <source>J Immunol.</source> (<year>2009</year>) <volume>182</volume>:<fpage>3782</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803126</pub-id><pub-id pub-id-type="pmid">19265157</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arimoto</surname> <given-names>K</given-names></name> <name><surname>Funami</surname> <given-names>K</given-names></name> <name><surname>Saeki</surname> <given-names>Y</given-names></name> <name><surname>Tanaka</surname> <given-names>K</given-names></name> <name><surname>Okawa</surname> <given-names>K</given-names></name> <name><surname>Takeuchi</surname> <given-names>O</given-names></name> <etal/></person-group>. <article-title>Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2010</year>) <volume>107</volume>:<fpage>15856</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1004621107</pub-id><pub-id pub-id-type="pmid">20724660</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pertel</surname> <given-names>T</given-names></name> <name><surname>Hausmann</surname> <given-names>S</given-names></name> <name><surname>Morger</surname> <given-names>D</given-names></name> <name><surname>Zuger</surname> <given-names>S</given-names></name> <name><surname>Guerra</surname> <given-names>J</given-names></name> <name><surname>Lascano</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>TRIM5 is an innate immune sensor for the retrovirus capsid lattice</article-title>. <source>Nature.</source> (<year>2011</year>) <volume>472</volume>:<fpage>361</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature09976</pub-id><pub-id pub-id-type="pmid">21512573</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname> <given-names>X</given-names></name> <name><surname>Tang</surname> <given-names>T</given-names></name> <name><surname>Jin</surname> <given-names>T</given-names></name> <name><surname>Ding</surname> <given-names>C</given-names></name> <name><surname>Zhou</surname> <given-names>R</given-names></name> <name><surname>Jiang</surname> <given-names>W</given-names></name></person-group>. <article-title>TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity</article-title>. <source>J Exp Med.</source> (<year>2017</year>) <volume>214</volume>:<fpage>459</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20160592</pub-id><pub-id pub-id-type="pmid">28031478</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>Zhao</surname> <given-names>W</given-names></name> <name><surname>Zhao</surname> <given-names>K</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Gao</surname> <given-names>C</given-names></name></person-group>. <article-title>TRIM26 negatively regulates interferon-&#x003B2; production and antiviral response through polyubiquitination and degradation of nuclear IRF3</article-title>. <source>PLoS Pathog.</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004726</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004726</pub-id><pub-id pub-id-type="pmid">25763818</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>C</given-names></name> <name><surname>Jia</surname> <given-names>M</given-names></name> <name><surname>Song</surname> <given-names>H</given-names></name> <name><surname>Yu</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <etal/></person-group>. <article-title>The E3 ubiquitin ligase TRIM40 attenuates antiviral immune responses by targeting MDA5 and RIG-I</article-title>. <source>Cell Rep.</source> (<year>2017</year>) <volume>21</volume>:<fpage>1613</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.020</pub-id><pub-id pub-id-type="pmid">29117565</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chelbi-Alix</surname> <given-names>MK</given-names></name> <name><surname>Quignon</surname> <given-names>F</given-names></name> <name><surname>Pelicano</surname> <given-names>L</given-names></name> <name><surname>Koken</surname> <given-names>MH</given-names></name> <name><surname>de The</surname> <given-names>H</given-names></name></person-group>. <article-title>Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein</article-title>. <source>J Virol.</source> (<year>1998</year>) <volume>72</volume>:<fpage>1043</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.72.2.1043-1051.1998</pub-id><pub-id pub-id-type="pmid">9444998</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname> <given-names>A</given-names></name> <name><surname>Kajaste-Rudnitski</surname> <given-names>A</given-names></name> <name><surname>Oteiza</surname> <given-names>A</given-names></name> <name><surname>Nicora</surname> <given-names>L</given-names></name> <name><surname>Towers</surname> <given-names>GJ</given-names></name> <name><surname>Mechti</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation</article-title>. <source>J Virol.</source> (<year>2013</year>) <volume>87</volume>:<fpage>4523</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02548-12</pub-id><pub-id pub-id-type="pmid">23408607</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname> <given-names>G</given-names></name> <name><surname>Zhao</surname> <given-names>M</given-names></name> <name><surname>Song</surname> <given-names>K</given-names></name> <name><surname>Hao</surname> <given-names>W</given-names></name> <name><surname>Bouchereau</surname> <given-names>D</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>TRIM41-mediated ubiquitination of nucleoprotein limits influenza a virus infection</article-title>. <source>J Virol.</source> (<year>2018</year>) <volume>92</volume>:<fpage>e00905</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00905-18</pub-id><pub-id pub-id-type="pmid">29899090</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants from the National Natural Science Foundation of China (U1501212, 31872497), the Natural Science Foundation of Guangdong Province (2016A030308001), the National Key Research and Development Program of China (2016YFD0500207), the Science and Technology Projects of Guangzhou (201904010022), and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-41-G16).</p></fn>
</fn-group>
</back>
</article>